September 10, 2006
Previously published by LexisNexis® Martindale-Hubbell® Counsel To Counsel Magazine on November 2005
In-house counsel shoulder significant
responsibility when guiding a
pharmaceutical product rollout. Having to
conform to the laws of many countries
makes the job even harder, as counsel need
to be aware of intellectual property rights,
trademark strategies and liability exposure.
Yet despite the burden counsel face, too
many companies are forging ahead
underprepared to meet the challenge of
launching a product in many countries.
By Counsel To Counsel Editor Brendan Coffey
|